-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LsInxDj8hS5VavhVTtu0Mt1P71Ll+F9L32GVuXZZ1mKxktYBrXTd8bdrjHIFYxJJ faIoceWk1X3KdtcmolZLww== 0000950133-05-004608.txt : 20051017 0000950133-05-004608.hdr.sgml : 20051017 20051017115502 ACCESSION NUMBER: 0000950133-05-004608 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051017 DATE AS OF CHANGE: 20051017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MGI GP, Inc. CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-82397 FILM NUMBER: 051140384 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 MAIL ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 FORMER COMPANY: FORMER CONFORMED NAME: GUILFORD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19940329 POS AM 1 w1330910posam.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 posam
 

As filed with the Securities and Exchange Commission on October 17, 2005
Registration No. 333-82397
 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
MGI GP, INC.
(Exact name of registrant as specified in its charter)
     
Delaware   52-1841960
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
6611 Tributary Street
Baltimore, MD 21224
(410) 631-6300
(Address, including zip code, of registrant’s principal executive offices)
 
Dean J. Mitchell
President
MGI GP, INC.
6611 Tributary Street
Baltimore, MD 21224
(410) 631-6300
(name, address, including zip code, and telephone number, including area code, of agent for
service)
Copies to:
Michael J. Silver
Hogan & Hartson L.L.P.
111 S. Calvert Street, Suite 1600
Baltimore, Maryland 21202
(410) 659-2741
 

 

 

DEREGISTRATION OF SECURITIES
     This Post-Effective Amendment No. 1 to Form S-3 relates to the Registration Statement on Form S-3 (File No. 333-82397) (the “Registration Statement”) filed with the Securities and Exchange Commission by Guilford Pharmaceuticals Inc. (“Guilford”). The Registration Statement registered the sale of up to 312,933 shares of common stock, $.01 par value per share, including the attached Series A Junior Participating Preferred Share Purchase Rights, issuable upon the exercise of warrants of the Registrant.
     On October 3, 2005, pursuant to the Agreement and Plan of Merger, dated as of July 20, 2005, among MGI PHARMA, INC. (“MGI PHARMA”), Granite Acquisition, Inc. (“Merger Sub”) and Guilford, Merger Sub was merged with and into Guilford (the “Merger”), and Guilford was the surviving company. In connection with the Merger, Guilford amended its Certificate of Incorporation to change its name to MGI GP, INC. MGI GP, INC. is now a direct wholly-owned subsidiary of MGI PHARMA.
     All securities previously registered under the Registration Statement that remain unsold are hereby deregistered.

 

 

 
SIGNATURES
     Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Baltimore, State of Maryland, on October 10, 2005.
         
    MGI GP, INC.
 
  By:   /s/ Dean J. Mitchell    
    Dean J. Mitchell   
    President   
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, this Post-Effective Amendment No. 1 to the Registrant Statement has been signed by the following persons in the capacities and on the date indicated.
         
Date: October 10, 2005
  /s/ Leon O. Moulder, Jr.    
 
       
 
  Leon O. Moulder, Jr.    
 
  Chief Executive Officer and Director    
 
  (Principal Executive Officer)    
 
        
Date: October 10, 2005
  /s/ James C. Hawley    
 
       
 
  James C. Hawley    
 
  Chief Financial Officer    
 
  (Principal Financial and Accounting Officer)    
 
        
Date: October 10, 2005
  /s/ William F. Spengler    
 
       
 
  William F. Spengler    
 
  Director    
 
        
Date: October 10, 2005
  /s/ Eric P. Loukas
 
Eric P. Loukas 		   
 
  Director    

-----END PRIVACY-ENHANCED MESSAGE-----